
Betaloc25 mg
Drug International Ltd.
Metoprolol Tartrate is a cardioselective beta-1 adrenergic receptor blocker.
Metoprolol Tartrate is a cardioselective beta-1 adrenergic receptor blocker. Its FDA-approved and well-established indications include:
Guideline-supported and commonly used off-label indications include:
Note: Metoprolol Tartrate is the immediate-release salt form, typically dosed multiple times daily, and is a distinct product from extended-release metoprolol succinate, which is dosed once daily and is separately approved for chronic heart failure.
| Indication | Adult Dosage |
|---|---|
| Hypertension | Initial: 100 mg/day in single or divided doses; usual maintenance range 100-450 mg/day in divided doses, titrated to response. |
| Angina pectoris | Initial: 100 mg/day in two divided doses; may increase gradually at weekly intervals up to 400 mg/day. |
| Myocardial infarction (early treatment) | In hospital, under close monitoring, followed by 100 mg twice daily by mouth for at least 3 months if tolerated, per treating physician's protocol. |
| Atrial fibrillation/flutter (rate control, off-label) | Individualized dosing, typically 25-100 mg twice daily, per physician judgment. |
Metoprolol Tartrate tablets should be taken with or immediately after meals to ensure consistent absorption. Doses should be taken at evenly spaced intervals.
Renal impairment: No specific dose adjustment is generally required as metoprolol is primarily hepatically metabolized, but caution and clinical monitoring are advised in severe renal impairment.
Hepatic impairment: Since Metoprolol Tartrate undergoes extensive hepatic metabolism, lower doses and careful titration are recommended in patients with significant hepatic impairment.
Important: Do not stop Metoprolol Tartrate abruptly. Discontinuation should be gradual, tapered over 1-2 weeks, under medical supervision, to avoid rebound hypertension, tachycardia, worsening angina, or myocardial infarction.
Common side effects of Metoprolol Tartrate include:
Less common but serious side effects requiring prompt medical attention include severe bradycardia, worsening heart failure (swelling, weight gain, breathlessness), bronchospasm (especially in patients with reactive airway disease), and heart block. See Precautions and Warnings for abrupt-discontinuation risks.
Metoprolol Tartrate is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.